Identification of substituted 4-Aminopiperidine (cas 13035-19-3)s and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity

Add time:09/24/2019    Source:sciencedirect.com

A substituted 4-aminopiperidine was identified as showing activity in an MCH assay from an HTS effort. Subsequent structural modification of the scaffold led to the identification of a number of active MCH antagonists. 3,5-Dimethoxy-N-(1-(naphthalen-2-ylmethyl)piperidin-4-yl)benzamide (5c) was among those with the highest binding affinity to the MCH receptor (Ki = 27 nM), when variations were made at benzoyl and naphthylmethyl substitution sites from the initial HTS hit. Further optimization via piperidine ring contraction resulted in enhanced MCH activity in a 3-aminopyrrolidine series, where (R)-3,5-dimethoxy-N-(1-(naphthalen-2-ylmethyl)-pyrrolidin-3-yl)benzamide (10i) was found to be an excellent MCH antagonist (Ki = 7 nM).

We also recommend Trading Suppliers and Manufacturers of 4-Aminopiperidine (cas 13035-19-3). Pls Click Website Link as below: cas 13035-19-3 suppliers

Prev:1,3-Disubstituted 4-Aminopiperidine (cas 13035-19-3)s as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors
Next:Bis-(acrylamide)s as new cross-linkers for resin-based composite restoratives)